statistical considerations in the clinical development of novel cancer therapies
Published 4 years ago • 705 plays • Length 1:08:22Download video MP4
Download video MP3
Similar videos
-
57:15
statistics in studies using cancer cell lines
-
1:52
how new cancer therapies are safely developed - university hospitals seidman cancer center
-
53:58
iddi webinar: the need for better endpoints: towards a more efficient drug development in oncology
-
26:04
keynote lecture 6: statistics for clinicians
-
1:09:07
from laboratory to bedside: expediting development of novel rare cancer treatments
-
12:39
title optimizing cancer treatment with multi armed bandits problem statement you are a data scientis
-
9:23
why don't we all have cancer?
-
11:30
living with stage 4 cervical cancer | my first signs and symptoms (leanne's story)
-
11:51
understanding cancer survival rates
-
4:04
cancer statistics | did you know?
-
56:42
statistical considerations for phase ii clinical trials and adaptive designs
-
1:06:19
statistical considerations for phase iii randomized trials, interim analysis, and data monitoring
-
24:09
understanding oncology statistics: how to determine the best treatments for a patient's cancer?
-
0:59
understanding scc head & neck cancer: statistics
-
1:00:09
what do all those lines and colors mean? interpreting cancer data plots.
-
2:07:50
statistical considerations: phase 1 & 2 clinical trials
-
56:36
transforming oncology clinical development with adaptive studies
-
3:26
the importance of clinical studies to cancer research
-
11:13
6.6 - cancer: adaptive chemotherapy
-
4:49
curesearch - the power of clinical trials
-
21:56
modern oncology research with adaptive trials
-
12:31
cancer is highly variable: severity and cost explained